COMET challenges paradigm of ACE inhibition in mild heart failure.
D002227:Carbazoles / Q000008:administration & dosage*; D000077261:Carvedilol; D002986:Clinical Trials as Topic; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D005260:Female; D005500:Follow-Up Studies; D006333:Heart Failure / Q000175:diagnosis / Q000188:drug therapy* / Q000401:mortality; D006801:Humans; D008297:Male; D011412:Propanolamines / Q000008:administration & dosage*; D018570:Risk Assessment; D012720:Severity of Illness Index; D016019:Survival Analysis; D013654:Taurine / Q000031:analogs & derivatives* / Q000037:antagonists & inhibitors*; D017216:Telemedicine; D016896:Treatment Outcome
D002227:Carbazoles; D011412:Propanolamines; D000077261:Carvedilol; D013654:Taurine; C024789:N-(2-acetamido)-2-aminoethanesulfonic acid